AIDS/HIV Vaccine
Low-dose mucosal SIV challenge has same kinetics as high-dose challenge
Published in Vaccine Weekly, May 5th, 2004
According to published research from the United States, "Simian immunodeficiency virus (SIV) challenge of rhesus macaques provides a relevant model for the assessment of human immunodeficiency virus (HIV) vaccine strategies. To ensure that all macaques become infected, the vaccinees and controls are exposed to large doses of pathogenic SIV. These nonphysiological high-dose challenges may adversely affect vaccine evaluation by overwhelming potentially efficacious vaccine responses.
"To determine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-05-05)
More Articles from Vaccine Weekly
- Cancer Vaccine
DNA vaccines encoding ras epitopes and B7.1 reduced tumor burden in rats - Cancer Vaccine
Dendritic cell subsets induce antigen-specific cytotoxic T cell responses - Human Papillomavirus Vaccine
DNA vaccine expressing L1 protein protects against papillomavirus challenge - Malaria Vaccine
Modified RESA protein peptide 6671 induces protection against malaria - Periodontal Health
Immunoreactivity in P. gingivalis recognized by human serum - AIDS/HIV Vaccine
Attenuated SIV vaccine provides early protection against viral infection - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
